Release date: 2024-08-23 15:50:02 Article From: Lucius Laos Recommended: 168
Koselugo is a targeted therapy that targets specific cancers by inhibiting the activity of key enzymes to block the growth of cancer cells.
There are two points to be concerned about the interaction between Koselugo and cardiovascular drugs:
Koselugo may affect cardiac function, such as reducing left ventricular ejection fraction, and concomitant use with cardiovascular drugs such as β-blockers may increase the risk of arrhythmias;
Koselugo may enhance the antihypertensive effect of some cardiovascular drugs, resulting in hypotension that needs to be closely monitored for changes in blood pressure when used in combination with antihypertensive drugs. If combination cardiovascular therapy is required during Koselugo use, the risks should be carefully assessed and the dose of the drug should be adjusted as appropriate.
In order to gain insight into the safety profile of Koselugo, we have to pay attention to its potential interactions with other drugs. Interactions with cardiovascular medications, in particular, can have an important impact on a patient's cardiovascular health. Next, we will explore the response to these interactions to ensure the safety of patients.
Responses to Koselugo and cardiovascular drug interactions include:
Regularly monitor cardiac function, such as electrocardiogram and echocardiography, to detect and deal with arrhythmias, decreased cardiac function, and other problems in a timely manner;
When used in combination with antihypertensive drugs, closely monitor changes in blood pressure and adjust the dose of the drug according to blood pressure to avoid the risk of low blood pressure. At the same time, patients should follow the doctor's instructions during the use of Koselugo and avoid increasing or decreasing the drug dose or changing the medication regimen on their own.
Given the possible interactions between Koselugo and cardiovascular drugs, appropriate measures need to be taken to mitigate the potential risks. At the same time, it is also important to understand and follow the daily precautions for Koselugo to ensure treatment effectiveness and patient safety.
Dietary considerations for Koselugo include:
Avoid eating large amounts of foods rich in vitamin E, as Koselugo capsules already contain vitamin E, and excessive intake may increase the risk of bleeding;
Maintain a balanced diet and consume more nutritious foods, such as proteins, vitamins, etc., to enhance physical fitness and improve the body's tolerance to medications. At the same time, pay attention to food hygiene and avoid eating expired or spoiled food to prevent adverse reactions.
【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: